OpenAlex
PricingAboutJobs
Log inGet started
Work

The Future of Immune Checkpoint Cancer Therapy After PD-1 and CTLA-4

HTML

Year: 2017
Type: review
Source: Immunotherapy
DOI: 10.2217/imt-2017-0024
Authors: Andrew W Hahn, David M Gill, Sumanta K Pal, Neeraj Agarwal
Institutions: University of Utah, City Of Hope National Medical Center, City of Hope, Huntsman Cancer Institute
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: immune checkpoint inhibitors, PD-1, CTLA-4, co-inhibitory receptors, costimulatory receptors, TNF receptor superfamily, monoclonal antibodies, cancer immunotherapy, combination therapy, T cell signaling, tumor immunology
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2728903533
FWCI: 1.423
Cites: 115
Cited by: 124
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security